| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Erratum |
In the article by J. Rieusset et al. (Mol Endocrinol 16:26282644, 2002), the FXR agonist described as GW1358 was mislabeled; the correct compound designation is GW4064 (see P. R. Maloney et al., J Med Chem 43:23712974, 2000). The authors regret the error.
| ||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |